A phase I study of mesothelin-targeted immunotoxin LMB-100 in combination with nab-paclitaxel for patients with previously treated advanced pancreatic cancer.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Christine Campo Alewine, Raffit Hassan, M. Iqra Ahmad, Jane B Trepel, Cody Peer, William Douglas Figg, Ira Pastan
Institutions: National Cancer Institute, Center for Cancer Research
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2914339779